A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Clinical trial NCT04804033 · TERMINATED
Trial details
- NCT number
- NCT04804033
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2024-03-21
- Enrollment
- 1753
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.